Here are four quick notes:
1. The purchased 15,000 shares are worth $305,100.
2. K2M now accounts for about 0.31 percent of Deimos Asset Management’s portfolio.
3. On Jan. 3, 2017, K2M opened trading at $20.27 and ended at $20.34.
4. K2M has a market capitalization of $858 million.
More articles on devices:
House introduces bill to permanently repeal medical device tax: 4 things to know
Titan Medical names David McNally new CEO — 7 key points
NuVasive receives approval to continue XLIF procedures in Japan— 6 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
